Edition:
United Kingdom

Karo Pharma AB (KARO.ST)

KARO.ST on Stockholm Stock Exchange

44.60SEK
19 Feb 2019
Change (% chg)

-- (--)
Prev Close
44.60kr
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,345,839
52-wk High
44.95kr
52-wk Low
25.25kr

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 395.33 0.340
Jun '18 489.45 3.860
Mar '18 267.06 0.424
FY 2017 Dec '17 238.72 -0.399
Sep '17 137.09 0.128
Jun '17 142.46 0.176
Mar '17 139.33 0.231
 
*Note: Units in Millions ofSwedish Krona
**Note: Units in Swedish Krona

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 1 2,027.00 2,027.00 2,027.00 --
Year Ending Dec-20 1 2,241.00 2,241.00 2,241.00 --
Earnings (per share)
Year Ending Dec-19 1 2.07 2.07 2.07 --
Year Ending Dec-20 1 2.47 2.47 2.47 --
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 20.39 69.44 33.70
P/E High - Last 5 Yrs. 17.52 147.79 49.87
P/E Low - Last 5 Yrs. 17.52 47.97 24.25
Beta 0.71 1.08 0.90
Price to Sales (TTM) 7.06 49.51 6.29
Price to Book (MRQ) 3.08 10.14 5.26
Price to Tangible Book (MRQ) -- 13.78 6.77
Price to Cash Flow (TTM) 19.20 56.20 24.98
% Owned Institutions -- 3.74 1.69

Dividends

  Company industry sector
Dividend Yield 0.70 0.12 1.40
Dividend Yield - 5 Year Avg 0.35 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) 0.00 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 73.93 205.92 12.75
Sales (TTM) vs TTM 1 Yr. Ago 100.57 48.79 5.84
Sales - 5 Yr. Growth Rate -- 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 541.36 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago 278.13 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate 15.70 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.25
Current Ratio (MRQ) 2.25 3.50 3.08
LT Debt to Equity (MRQ) 45.78 18.65 11.38
Total Debt to Equity (MRQ) 45.78 31.33 16.12
Interest Coverage (TTM) -9.49 -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 50.37 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) 28.58 -- --
EBITD - 5 Yr. Avg -36.86 -110.40 12.87
Operating Margin (TTM) 20.58 -184.63 6.20
Operating Margin - 5 Yr. Avg. -43.06 -126.89 8.31
Pre-Tax Margin (TTM) 14.24 -175.33 7.16
Pre-Tax Margin - 5 Yr. Avg. -44.64 -132.68 8.61
Net Profit Margin (TTM) 28.74 -182.03 3.30
Net Profit Margin - 5 Yr. Avg. -30.81 -137.07 4.89
Effective Tax Rate (TTM) -101.89 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 6,716,145 7,654,601 842,398,385
Net Income/Employee (TTM) 1,930,536 562,114 99,842,801
Receivable Turnover (TTM) -- 6.23 5.71
Inventory Turnover (TTM) -- 1.89 3.47
Asset Turnover (TTM) 0.37 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 10.69 6.39 11.06
Return on Assets - 5 Yr. Avg. -9.05 5.47 12.20
Return on Investment (TTM) 11.70 8.92 14.45
Return on Investment - 5 Yr. Avg. -13.05 6.78 15.87
Return on Equity (TTM) 15.82 10.08 15.96
Return on Equity - 5 Yr. Avg. -18.16 8.32 17.00
  1 Year 3 Year 5 Year
Sales % 402.58 94.73 --
EPS (TTM) % 192.15 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Karo Pharma AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 3.65 -- 99 99
13 Week -2.93 -- 88 95
26 Week 19.15 -- 99 98
52 Week 13.66 -- 99 72
YTD 51.68 -- 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 70.28%
# of Holders: 25
Total Shares Held: 115,490,297
3 Mo. Net Change: 67,250,110
# New Positions: 6
# Closed Positions: 7
# Increased Positions: 16
# Reduced Positions: 11
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.